Brief: Hoth Therapeutics Receives Uspto Filing Receipt For Ht-001 Formulation Patent Application, Expanding Existing Patent Coverage
31/03/2025 23:28
March 31 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS RECEIVES USPTO FILING RECEIPT FOR HT-001 FORMULATION PATENT APPLICATION, EXPANDING EXISTING PATENT COVERAGE Source text: ID:nPn7rYBkga Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology